Drugs for Panic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 117)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Methylphenidate |
Approved, Investigational |
Phase 4 |
|
113-45-1 |
4158 |
Synonyms:
4311/B Ciba
alpha-Phenyl-2-piperidineacetate methyl ester
alpha-Phenyl-2-piperidineacetic acid methyl ester
a-Phenyl-2-piperidineacetate methyl ester
a-Phenyl-2-piperidineacetic acid methyl ester
Calocain
Celltech brand OF methylphenidate hydrochloride
Centedein
Centedrin
Centedrine
Centredin
Cephalon brand OF methylphenidate hydrochloride
Concerta
Concerta®|Jornay PM® (a.k.a. HLD200)|Ritalin®
COTEMPLA XR-ODT
Daytrana
D-Methylphenidate HCL
Equasym
Focalin
Focalin XR
Hydrochloride, methylphenidate
Mallinckrodt brand OF methylphenidate hydrochloride
Meridil
Metadate
Metadate CD
Metadate ER
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl alpha-phenyl-alpha-2-piperidinylacetic acid
Methyl a-phenyl-a-(2-piperidyl)acetate
Methyl a-phenyl-a-(2-piperidyl)acetic acid
Methyl a-phenyl-a-2-piperidinylacetate
Methyl a-phenyl-a-2-piperidinylacetic acid
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenidylacetic acid
methyl phenyl(piperidin-2-yl)acetate
Methyl phenyl(piperidin-2-yl)acetic acid
|
Methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetic acid
Methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetic acid
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate HCL
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidic acid
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MPH
Novartis brand 1 OF methylphenidate hydrochloride
Novartis brand 2 OF methylphenidate hydrochloride
Phenidylate
Plimasine
PMS-Methylphenidate
Riphenidate
Ritalin
Ritalin hydrochloride
Ritalin LA
Ritalin SR
Ritaline
Ritalin-SR
Ritcher Works
Tsentedrin
Α-phenyl-2-piperidineacetate methyl ester
Α-phenyl-2-piperidineacetic acid methyl ester
|
|
2 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
3 |
|
Diphenhydramine |
Approved, Investigational |
Phase 4 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
[2-(DIPHENYLMETHOXY)ETHYL]DIMETHYLAMINE
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
ANTITUSSIVE
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
BELDIN
BELIX
Benadryl
BENADRYL PRESERVATIVE FREE
Benadryl®|benzhydramine|dimehydrinate
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
CALADRYL
Citrate, diphenhydramine
COLTEX
DIBENIL
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
DIMEHYDRINATE
Dimethylamine benzhydryl ester
Diphamine
Diphantine
|
DIPHEN
DIPHENHYDRAMINE
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
DIPHENHYDRAMINE HCL
Diphenhydramine hydrochloride
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
DREEMON
DYTUSS
FEDRIL
GPPE COUGH EXPECT PAED
GPPE ORAL SOLN
HISTERGAN
HYDRAMINE
Hydrochloride, diphenhydramine
MEDINEX
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
NIGHTCALM
NSC-33299
NYTOL
NYTOL ONE-A-NIGHT
O-Benzhydryldimethylaminoethanol
PAXIDORM
Restamin
SILPHEN
SLEEPIA
SYNTEDRIL
TIXYLIX CATARRH
VICKS FORMULA 44
Α-(2-dimethylaminoethoxy)diphenylmethane
Î’-dimethylaminoethanol diphenylmethyl ether
Î’-dimethylaminoethyl benzhydryl ether
|
|
4 |
|
Suvorexant |
Approved, Investigational |
Phase 4 |
|
1030377-33-3 |
57505028 24965990 |
Synonyms:
BELSOMRA
Belsomra®|DORA-analogue|MK 4305|MK-4305
DORA-ANALOGUE
MK 4305
|
MK4305
MK-4305
SUVOREXANT
|
|
5 |
|
Promethazine |
Approved, Investigational |
Phase 4 |
|
60-87-7 |
4927 |
Synonyms:
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
Atosil
Diphergan
Diprazin
Hydrochloride, promethazine
Isopromethazine
Lilly 1516
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
NSC-30321
Phenargan
Phenergan
Phenergan®|Sominex®
Phensedyl
Pipolfen
Pipolphen
Proazaimine
Proazamine
|
Promazinamide
Promet
Prometazin
Prometazina
Prometazine
PROMETHACON
Promethazin
PROMETHAZINE
Promethazine hydrochloride
Promethazinum
PROMETHEGAN
Promethiazine
Promezathine
Prothazin
Prothazine
Pyrethia
Remsed
RP-3277
Rumergan
SOMINEX
ZIPAN-25
ZIPAN-50
|
|
6 |
|
Duloxetine |
Approved |
Phase 4 |
|
136434-34-9, 116539-59-4 |
60835 |
Synonyms:
(+-)-duloxetine
(3S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine
(S)-duloxetine
ARICLAIM
Cymbalta
Cymbalta®|LY248686
DUCILTIA
Duloxetina
Duloxetine
Duloxetine ethanedioate (1:1), (+-)-isomer - T353987
Duloxetine HCL
Duloxetine hydrochloride
|
Duloxetine, (+)-isomer
HCL, Duloxetine
Hydrochloride, duloxetine
LY 248686
LY248686
LY-248686
LY248686 HCL
LY-248686 HCL
N-Methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine
N-Methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide
Yentreve
|
|
7 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
8 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
9 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Antelepsin
Chlonazepam
CLONAZEPAM
CLONAZEPAM CIV
Clonazepam fine granules
Clonazepam tablets
|
Clonazepamum
Klonopin
KLONOPIN RAPIDLY DISINTEGRATING
Klonopin®|Ro-5-4023|Ro-54023
NSC-179913
Rivotril
RO-54023
RO-5-4023
RO-5423
|
|
10 |
|
Clozapine |
Approved |
Phase 4 |
|
5786-21-0 |
2818 135398737 |
Synonyms:
Asaleptin
CLORAZIL
Clorazil®|HF-1854
Clozapin
Clozapina
CLOZAPINE
CLOZAPINE RESOLUTION MIXTURE
Clozapinum
Clozaril
|
FAZACLO
FAZACLO ODT
HF-1854
Iprox
Leponex
Lepotex
LEX123
VERSACLOZ
ZAPONEX
|
|
11 |
|
Vortioxetine |
Approved, Investigational |
Phase 4 |
|
508233-74-7 |
9966051 |
Synonyms:
1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine
1-{2-[(2,4-dimethylphenyl)sulphanyl]phenyl}piperazine
Brintellix
Brintellix®|Lu AA21004|Trintellix®
LU AA21004
LUAA21004
LU-AA21004
|
TRINTELLIX
VORTIOXETINA
VORTIOXETINE
VORTIOXÉTINE
Vortioxetine hydrobromide
VORTIOXETINUM
|
|
12 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
Abilify
ABILIFY MAINTENA
ABILIFY MAINTENA KIT
ABILIFY MYCITE KIT
Abilify®|Aripiprex®|Aristada® (aripiprazole lauroxil)|OPC 14597|OPC-14597
Abilitat
Aripiprazol
|
ARIPIPRAZOLE
Aripiprazolum
ARIPIPREX
OPC 14597
OPC 31
OPC-14597
OPC-31
|
|
13 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 Propylpentanoic acid
2-N-PROPYL-4-PENTENOIC ACID
2-N-Propyl-N-valerate
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-Propylpentanoic acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-Propylvaleric acid
44089
4-Heptanecarboxylate
4-Heptanecarboxylic acid
A-44090
A-44090|Depakote®|Epilim®|valproate sodium
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acido valproico
ácido valproico
Acidum valproicum
Alti-valproic
Apo-divalproex
Apo-valproic
Apo-valproic syrup
Avugane
Baceca
Calcium valproate
Calcium, valproate
Convulex
Convulsofin
Delepsine
Depacon
Depakene
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Deproic
Di-N-propylacetate
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-n-propylessigsäure
Dipropyl acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DOM-divalproex
Dom-valproate
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
Epiject i.v.
Epilex
Epilim
|
Epival
Epival er
Ergenyl
Gen-divalproex
Kyselina 2-propylvalerova
LEP321
Magnesium valproate
Med valproic
Mylproin
Myproate
Myproic acid
N-Dipropylacetic acid
N-DPA
Novo-divalproex
Novo-valproic
Novo-valproic - ecc
Novo-valproic soft gel cap
NSC-93819
Nu-valproic
PEAC
Penta-valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
Ratio-valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
Sandoz valproic
Savicol
Semisodium valproate
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
Sprinkle
STAVZOR
Valcote
Valparin
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
VALPROIC ACID
Valproic acid usp
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
|
|
14 |
|
Ziprasidone |
Approved |
Phase 4 |
|
146939-27-7 |
60854 |
Synonyms:
5-(2-(4-(3-Benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
CP-88059
CP-88059|CP-88059-27|CP-880591|CP-8805927|Geodon®
CP-880591
CP-8805927
CP-88059-27
Geodon
Geodon Oral
Zeldox
|
Zipradon
Ziprasidona
Ziprasidone
Ziprasidone hydrochloride
Ziprasidone hydrochloride, monohydrate
Ziprasidone mesylate trihydrate
Ziprasidonum
Ziprazidone
|
|
15 |
|
Alprazolam |
Approved, Illicit, Investigational |
Phase 4 |
|
28981-97-7 |
2118 |
Synonyms:
8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine
Alphapharm brand OF alprazolam
Alplax
ALPRAZOLAM
Alprazolam alphapharm brand
Alprazolam apotex brand
ALPRAZOLAM CIV
Alprazolam kenral brand
Alprazolam novopharm brand
Alprazolam nu-pharm brand
Alprazolam orion brand
Alprazolam pfizer brand
Alprazolam temmler brand
Alprazolan
Alpronax
Alprox
Alviz
ALZAM
Apo alpraz
Apo-alpraz
ApoAlpraz
Apotex brand OF alprazolam
Arzneimittelwerk dresden brand OF alprazolam
Bestrol
Cassadan
Constan
D 65MT
D65MT
D-65MT
Esparon
Frontal
|
Intensol
Kalma
Kenral brand OF alprazolam
KENTIUM
NIRAVAM
Niravam®|U-31889|Xanax®
Novo alprazol
Novo-alprazol
NovoAlprazol
Novopharm brand OF alprazolam
Nu alpraz
Nu pharm brand OF alprazolam
Nu-alpraz
NuAlpraz
Nu-pharm brand OF alprazolam
Orion brand OF alprazolam
Pfizer brand OF alprazolam
Ralozam
Restyl
Solanax
Tafil
Temmler brand OF alprazolam
Tranax
Trankimazin
Tranquinal
TUS-1
U 31,889
U-31889
Xanax
XANAX XR
Xanor
|
|
16 |
|
Sertraline |
Approved |
Phase 4 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
Altruline
Apo sertraline
Apo-sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
Boehringer ingelheim brand OF sertraline hydrochloride
cis-(+)-Sertraline
CP 51974
CP-519741
CP-51974-1
CP-51974-1|CP-519741|Lustral®|Zoloft®
Esteve brand OF sertraline hydrochloride
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
Hydrochloride, sertraline
Lacer brand OF sertraline hydrochloride
Lustral
|
Novo sertraline
Novopharm brand OF sertraline hydrochloride
Novo-sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Ratio sertraline
Ratiopharm brand OF sertraline hydrochloride
Ratio-sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
SERTRALINE
Sertraline hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
Sultamicillin Tosylate
Zoloft
|
|
17 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
18 |
|
Dopamine Uptake Inhibitors |
|
Phase 4 |
|
|
|
19 |
|
Orexin Receptor Antagonists |
|
Phase 4 |
|
|
|
20 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
21 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
22 |
|
Analgesics |
|
Phase 4 |
|
|
|
23 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
24 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
25 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
26 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
27 |
|
Serotonin 5-HT3 Receptor Antagonists |
|
Phase 4 |
|
|
|
28 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 4 |
|
|
|
29 |
|
Quetiapine Fumarate |
|
Phase 4 |
|
111974-72-2 |
|
Synonyms:
ICI-204636
QUETIAPINE FUMARATE
SEROQUEL
|
SEROQUEL XR
ZD-5077
ZM-204636
|
|
30 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
31 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
32 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
33 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
34 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
35 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
36 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
37 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
38 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
39 |
|
Venlafaxine |
Approved |
Phase 3 |
|
99300-78-4, 93413-69-5 |
5656 |
Synonyms:
1-(2-(dimethylamino)-1-(4-Methoxyphenyl)ethyl)cyclohexanol HCL
1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXAN-1-OL
ALVENTA XL
AMPHERO XL
BONILUX XL
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
DEPEFEX XL
Dobupal
Efectin
Efexor
EFEXOR XL
Effexor
EFFEXOR XR
Effexor®|WY-45030
Elafax
FORAVEN XL
Hydrochloride, venlafaxine
MENTAVEN XL
POLITID XL
RANFAXINE XL
RODOMEL XL
Sila venlafaxine
Sila-venlafaxine
SUNVENIZ XL
TARDCAPS XL
TIFAXIN XL
|
TONPULAR XL
Trevilor
TRIXAT XL
Vandral
VAXALIN XL
VENAXX XL
VENLABLUE XL
VENLADEX XL
Venlafaxin
Venlafaxina
Venlafaxina [INN-Spanish]
VENLAFAXINE
Venlafaxine [INN:Ban]
VENLAFAXINE HCL
Venlafaxine hydrochloride
Venlafaxinum
Venlafaxinum [INN-Latin]
Venlafexine
VENLALIC XL
VENLANEO XL
VENSIR XL
VEXARIN XL
VIEPAX
VIEPAX XL
WINFEX XL
WY-45030
|
|
40 |
|
Risperidone |
Approved, Investigational |
Phase 3 |
|
106266-06-2 |
5073 |
Synonyms:
Belivon
Buspirone
Consta, risperdal
LY03004
LY-03004
N05AX08
Okedi®|R-64-766|R-64766|Risperdal®
PERSERIS KIT
R-64,766
R-64766
R-64-766
RCN3028
RCN-3028
Rispen
Risperdal
Risperdal consta
RISPERDAL CONSTA LONG ACTING
|
RISPERDAL M
Risperdal m-tab
RISPERDAL QUICKLET
RISPERDONE
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Rispéridone
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
Sequinan
Spiron
|
|
41 |
|
Levetiracetam |
Approved |
Phase 3 |
|
102767-28-2 |
441341 5284583 |
Synonyms:
AGB-101
alpha Ethyl 2 oxo 1 pyrrolidineacetamide
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
DESITREND
e Keppra
ELEPSIA XR
Etiracetam
Etiracetam, R isomer
Etiracetam, R-isomer
Etiracetam, S isomer
Etiracetam, S-isomer
Keppra
KEPPRA XR
Keppra®|Spritam®|UCB L059|UCB-L 059
LEVETIRACETAM
Levetiracetam [INN]
LEVETIRACETAM IN SODIUM CHLORIDE
|
Levetiracetame
Levetiracetamum
Levetiracetamum [INN-Latin]
Levitiracetam
MATEVER
N03AX14
R-Isomer etiracetam
S-Isomer etiracetam
SPRITAM
UCB brand OF levetiracetam
Ucb L059
Ucb L060
UCB-22059
Ucb-L059
UcbL060
Ucb-L060
|
|
42 |
|
Cycloserine |
Approved |
Phase 3 |
|
68-41-7 |
6234 |
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-AMINOISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
ABBR DCS
a-Cycloserine
alpha-Cycloserine
Cicloserina
Cyclo-D-serine
CYCLOSERINE
Cyclosérine
Cycloserinum
D-(+)-Cycloserine
D-4-Amino-3-isoxazolidinone
D-4-Amino-3-isoxazolidone
DCS
D-CS
|
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
DL-Cycloserine
D-Oxamicina
D-Oxamycin
L-Cycloserine
NSC-154851
NSC-76029
Orientomycin
PA 94
PA-94
R-4-Amino-3-isoxazolidinone
Ro-1-9213
Seromycin
Α-cycloserine
|
|
43 |
|
Lecithin |
Approved, Experimental, Investigational, Nutraceutical |
Phase 3 |
|
8002-43-5, 1446756-47-3, 18656-38-7 |
26197 9547096 6323481 |
Synonyms:
(1)-(7-Myristoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphatricosyl)trimethylammonium 4-oxide
(2S)-2-Amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoate
[2-({[2,3-bis(tetradecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium
1,2 Dimyristoyl glycero 3 phosphorylcholine
1,2 Ditetradecanoyl glycero 3 phosphocholine
1,2 Ditetradecyl glycero 3 phosphocholine
1,2-Dimyristoyl-glycero-3-phosphorylcholine
1,2-Dimyristoyl-sn-glycero-3-phosphatidylcholine
1,2-Dioctadecanoyl-rac-glycero-3-phosphoserine
1,2-Dioctadecanoyl-sn-glycero-3-phosphoserine
1,2-Distearoyl-rac-glycero-3-phosphoserine
1,2-Ditetradecanoyl-glycero-3-phosphocholine
1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine
1,2-Ditetradecyl-glycero-3-phosphocholine
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphoric acid
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
3-O-sn-Phosphatidyl-L-serine
Acetylglucosamine
D-GlcNAc
dimyristoyl phosphatidylcholine
Dimyristoyllecithin
|
Dimyristoylphosphatidylcholine
Dimyristoyl-phosphatidylcholine
Distearoyl phosphatidylserine
distearoylphosphatidylserine|PS
DMCP
DMPC
Lecithins
l-α-dimyristoylphosphatidylcholine
N Acetyl D glucosamine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
O3-Phosphatidyl-L-serine
Phosphatidyl serine
Phosphatidylcholine
Phosphatidyl-L-serine
Phosphatidylserine
Phosphatidylserine(18:0/18:0)
Phosphatidylserine(36:0)
Phospholutein
PS
PS(18:0/18:0)
PS(36:0)
pSer(18:0/18:0)
pSer(36:0)
|
|
44 |
|
Xenon |
Experimental |
Phase 2, Phase 3 |
|
7440-63-3 |
|
Synonyms:
|
45 |
|
Nootropic Agents |
|
Phase 3 |
|
|
|
46 |
|
Anesthetics, Inhalation |
|
Phase 2, Phase 3 |
|
|
|
47 |
|
Anesthetics, General |
|
Phase 2, Phase 3 |
|
|
|
48 |
|
Anesthetics |
|
Phase 2, Phase 3 |
|
|
|
49 |
|
Sunflower |
|
Phase 3 |
|
|
|
50 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 217)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release |
Unknown status |
NCT00492414 |
Phase 4 |
Paroxetine CR |
2 |
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity |
Unknown status |
NCT03785223 |
Phase 4 |
Methylphenidate Hydrochloride Controlled-Release Capsules;Placebo Capsule |
3 |
Changes of Cerebral Glucose Metabolism Associated With the Fear Network Activity Before and After 12 Weeks of Escitalpram Treatment in Panic Disorder |
Completed |
NCT00767871 |
Phase 4 |
Lexapro |
4 |
The Role of Orexin in Human Panic Disorder |
Completed |
NCT02593682 |
Phase 4 |
suvorexant;placebo |
5 |
Phase 4 Study of Panic Disorder That Expresses to Change of Cerebral Glucose Metabolism After 12 Week of Paroxetine Treatment |
Completed |
NCT00767754 |
Phase 4 |
Paxil CR |
6 |
A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder |
Completed |
NCT00540098 |
Phase 4 |
paroxetine + aerobic exercise;Paroxetine + relaxation;Placebo + aerobic exercise;Placebo + relaxation |
7 |
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder |
Completed |
NCT00438971 |
Phase 4 |
Duloxetine |
8 |
A Randomized, Double-Blind, Multicenter Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder |
Completed |
NCT00677352 |
Phase 4 |
sertraline;Paroxetine |
9 |
Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment: a Clinical Randomized Trial |
Completed |
NCT00803400 |
Phase 4 |
Alprazolam;Alprazolam + Aerobic exercise |
10 |
Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression |
Completed |
NCT00031317 |
Phase 4 |
Paroxetine;Clozapine |
11 |
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder |
Completed |
NCT00167479 |
Phase 4 |
risperidone (Risperdal) |
12 |
A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder |
Completed |
NCT02395510 |
Phase 4 |
Vortioxetine |
13 |
A Randomized Double-Blind Comparison of Sertraline With Early Alprazolam XR Co-Administration vs Sertraline/Placebo for Primary Care Panic Disorder Patients |
Completed |
NCT00198094 |
Phase 4 |
Sertraline and Alprazolam XR |
14 |
A Multicenter, Randomized, Open-label, Parallel Design Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravamâ„¢ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder |
Completed |
NCT00266409 |
Phase 4 |
Niravam;SSRI/SNRI |
15 |
An 8-week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR Co-administration for SSRI-Resistant, Comorbid Panic Disorder |
Completed |
NCT00619892 |
Phase 4 |
quetiapine XR;placebo |
16 |
The Effects of Treatment With Sertraline for Panic Disorder and/or Depression Driven Chest Pain and/or Palpitations in a Double Blind, Care as Usual and Placebo Controlled Study |
Completed |
NCT01114100 |
Phase 4 |
sertraline;placebo |
17 |
Long-term, Open, Naturalistic, Randomized Clinical Trial With Clonazepam and Paroxetine in Panic Disorder With or Without Agoraphobia |
Completed |
NCT02852577 |
Phase 4 |
Clonazepam;Paroxetine |
18 |
Randomized Controlled Trial of Escitalopram Versus Placebo for Patients With Irritable Bowel Syndrome and Panic Disorder |
Completed |
NCT01551225 |
Phase 4 |
Escitalopram |
19 |
Aripiprazole for the Treatment of Refractory Anxiety: Impact on Clinical Outcomes, Resilience and Neuroendocrinologic Parameters |
Completed |
NCT00438386 |
Phase 4 |
Aripiprazole |
20 |
A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder. |
Completed |
NCT00579280 |
Phase 4 |
quetiapine SR;divalproex sodium ER;placebo |
21 |
12 Week Prospective Double Blind Placebo Controlled Randomized Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety |
Completed |
NCT00352469 |
Phase 4 |
Seroquel XR |
22 |
Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes |
Completed |
NCT00347269 |
Phase 4 |
Psychotropic medication optimization |
23 |
Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety |
Completed |
NCT03522844 |
Phase 4 |
Escitalopram |
24 |
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients (MOSAIC) |
Completed |
NCT01201967 |
Phase 4 |
|
25 |
A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder |
Completed |
NCT01172652 |
Phase 4 |
Ziprasidone;Placebo |
26 |
Pharmacotherapy in Depression With Panic Spectrum |
Completed |
NCT00177996 |
Phase 4 |
sertraline hydrochloride |
27 |
An Open-label Study to Assess the Safety and Tolerability of Xanax XR in the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks |
Terminated |
NCT00634790 |
Phase 4 |
alprazolam XR |
28 |
A Randomized, Double-blind, Placebo-controlled Study of Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder |
Terminated |
NCT00635531 |
Phase 4 |
alprazolam XR |
29 |
A Randomized, Double-blind, Placebo-controlled Study of Continuation Treatment With Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder |
Terminated |
NCT00635076 |
Phase 4 |
alprazolam XR |
30 |
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity |
Terminated |
NCT00182533 |
Phase 4 |
Sertraline;Placebo |
31 |
Mechanisms of CBT-Treatment Effects in Patients With Panic Disorder and Panic Disorder With Agoraphobia: The Role of Interoceptive Exposure |
Unknown status |
NCT01323556 |
Phase 2, Phase 3 |
|
32 |
Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial |
Completed |
NCT00845260 |
Phase 3 |
|
33 |
Treatment Refractory Panic Disorder |
Completed |
NCT00118417 |
Phase 2, Phase 3 |
Clonazepam;Sertraline |
34 |
A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder |
Completed |
NCT00044772 |
Phase 3 |
Venlafaxine ER |
35 |
A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder |
Completed |
NCT00038896 |
Phase 3 |
Venlafaxine ER |
36 |
Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine. |
Completed |
NCT00195598 |
Phase 3 |
VENLAFAXINE;Paroxetine |
37 |
Dynamic Treatment vs. CBT for Panic Disorder |
Completed |
NCT00353470 |
Phase 3 |
|
38 |
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks |
Completed |
NCT00279617 |
Phase 3 |
levetiracetam |
39 |
Randomized Controlled Trial of Psychodynamic Psychotherapy vs. Applied Relaxation for Panic Disorder |
Completed |
NCT00128388 |
Phase 2, Phase 3 |
|
40 |
Treatment of Panic Disorder: Long Term Strategies |
Completed |
NCT00000368 |
Phase 3 |
Paroxetine or other medication - algorithm used |
41 |
A Randomized, Controlled Study of a Stepped-care Model for the Treatment of Social Phobia and Panic Disorder in Adults |
Completed |
NCT00619138 |
Phase 3 |
|
42 |
Cognitive Behavioral Interventions That Target Personality Risk for Substance Abuse and Mental Illness: Delivery by Educational Professionals |
Completed |
NCT00776685 |
Phase 2, Phase 3 |
|
43 |
The RELAX Trial: Reducing Limitations From Anxiety in Primary Care |
Completed |
NCT00158327 |
Phase 3 |
|
44 |
Improving Quality of Primary Care for Anxiety Disorders |
Completed |
NCT00102427 |
Phase 2, Phase 3 |
|
45 |
A New School-based Drug Prevention Programme for Teenagers: Interventions That Target Personality Risk for Substance Abuse and Mental Illness |
Completed |
NCT00344474 |
Phase 2, Phase 3 |
|
46 |
Online Treatments for Mood and Anxiety Disorders in Primary Care |
Completed |
NCT01482806 |
Phase 2, Phase 3 |
|
47 |
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder |
Completed |
NCT00277654 |
Phase 3 |
Risperidone |
48 |
Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder: Comparison of Therapist-Led and Therapist Assisted Approaches |
Recruiting |
NCT04922502 |
Phase 2, Phase 3 |
|
49 |
A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder |
Not yet recruiting |
NCT04432155 |
Phase 2, Phase 3 |
Xenon;Placebo |
50 |
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study |
Not yet recruiting |
NCT03549819 |
Phase 3 |
Cannabidiol (CBD) Oil Capsules;Sunflower Lecithin Oil in Capsule |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Alprazolam
Clomipramine
Clomipramine Hydrochloride
Clonazepam
Diazepam
Fluoxetine
Fluoxetine Hydrochloride
Fluvoxamine
Fluvoxamine Maleate
Imipramine
Imipramine Hydrochloride
|
Imipramine pamoate
Maprotiline
Maprotiline Hydrochloride
Paroxetine
Paroxetine Hydrochloride
Propranolol
Propranolol Hydrochloride
Sertraline
Sertraline Hydrochloride
Temazepam
|
Cochrane evidence based reviews: panic disorder
|